Lexiscan

DRUG3 trials

Sponsors

Dana-Farber Cancer Institute, Medical University of South Carolina, St. Jude Children's Research Hospital

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseSickle Cell Disease

Phase 1

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

CompletedNCT01085201

Dana-Farber Cancer InstituteSickle Cell Disease

Start: 2010-04-30End: 2013-03-31Updated: 2014-03-07

Phase 2

Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System

CompletedNCT03103061

Medical University of South CarolinaCardiovascular Diseases, Coronary Artery Disease

Start: 2016-02-09End: 2018-06-14Updated: 2019-08-09

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

RecruitingNCT05583721

St. Jude Children's Research HospitalSickle Cell Disease

Start: 2023-10-10End: 2028-09-01Target: 40Updated: 2026-05-06

Related Papers

An evaluation of the relationship between abnormal myocardial perfusion and diastolic dysfunction in sickle cell disease using PET rest-stress myocardial perfusion imaging: Mypers

Blood2025-11-03